UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35331 ACADIA HEALTHCARE COMPANY, INC. (Exact name of registrant as specified in its charter) Delaware 45-2492228 (State or other jur ...

Core Viewpoint - Acadia Healthcare Company, Inc. is a prominent provider in the inpatient behavioral health care sector, focusing on delivering quality services while aiming for financial growth [1] Financial Performance - In Q4 2025, Acadia reported adjusted earnings of $0.07 per share, exceeding the Zacks Consensus Estimate of $0.03 per share, resulting in an earnings surprise of over 164% [2][6] - Despite the earnings surprise, the company's profit declined by 89% year-over-year, while total revenues reached $821.5 million, reflecting a 6.1% increase compared to the previous year, surpassing the expected $799 million [3][6] - The revenue growth was attributed to a 3.1% increase in patient days and a 2.5% rise in admissions, leading to a 4.4% increase in same-facility revenues [3] Future Projections - Acadia anticipates revenues for 2026 to be between $3.37 billion and $3.45 billion, with adjusted EBITDA projected to range from $575 million to $610 million [4][6] - The company's projections indicate a strategic focus on service expansion and operational efficiency optimization, despite challenges such as a decrease in average length of stay and rising expenses [4] Stock Performance - Currently, ACHC's stock price is $21.48, reflecting a 3.09% increase, with fluctuations between a low of $20.88 and a high of $22.27 during the trading day [5] - Over the past year, the stock has seen a high of $42.85 and a low of $11.43, with a market capitalization of approximately $1.94 billion [5]

Core Viewpoint - Acadia Healthcare is a leading provider in the inpatient behavioral health care sector, recognized for its strong performance and unique market position [1]. Financial Performance - In the fourth quarter, Acadia reported adjusted earnings of $0.07 per share, exceeding the Zacks Consensus Estimate of $0.03, resulting in an earnings surprise of +164.15%. This is a decrease from $0.64 per share in the same quarter last year, but the company has consistently surpassed consensus EPS estimates over the last four quarters [3]. - Total revenues for the quarter reached $821.5 million, surpassing the expected $799 million, marking a 6.1% year-over-year increase driven by higher patient days and admissions, as well as increased revenues per patient day. However, this growth was partially offset by a shorter average length of stay and increased expenses [4]. Future Outlook - Acadia anticipates 2026 revenues to be between $3.37 billion and $3.45 billion, with adjusted EBITDA projected to range from $575 million to $610 million [5][6]. - Following the announcement of its fourth-quarter and full-year 2025 results, Acadia's stock experienced a 23% surge, benefiting from a broader market upswing, with a market capitalization of approximately $2 billion [5]. Analyst Ratings - Raymond James maintained an "Outperform" rating for Acadia Healthcare, indicating confidence in the company's future performance despite a recommendation to "hold" the stock [2][6].

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over 5 years, and has put together detailed reports of over 1,000 companies. He leads the investing group Haggerston B ...

Group 1 - The article promotes a weekly newsletter focused on stocks in the biotech, pharma, and healthcare industries, highlighting key trends and catalysts that influence market valuations [1] - Edmund Ingham, a biotech consultant with over 5 years of experience, leads the Haggerston BioHealth investing group, which caters to both novice and experienced investors [1] - The investing group provides insights such as buy and sell ratings, product sales forecasts for major pharmaceutical companies, integrated financial statements, discounted cash flow analysis, and market-specific analyses [1]

Key Takeaways ACHC beat Q4 earnings and revenue estimates as admissions and patient days increased.ACHC's same-facility revenues rose 4.4% on 3.1% higher patient days and 2.5% admissions growth.ACHC sees 2026 revenues of $3.37B-$3.45B and adjusted EBITDA of $575M-$610M.Acadia Healthcare Company, Inc. (ACHC) reported adjusted fourth-quarter earnings of 7 cents per share, which beat the Zacks Consensus Estimate of 3 cents. However, the bottom line declined 89% year over year.Total revenues increased 6.1% year ...

Acadia Healthcare (ACHC) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.64 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +164.15%. A quarter ago, it was expected that this provider of inpatient behavioral health care services would post earnings of $0.67 per share when it actually produced earnings of $0.72, delivering a surprise o ...

The stock is moving higher as the broader market is experiencing gains, with the Nasdaq up 1.23%.Earnings SnapshotAcadia Healthcare reported fourth-quarter adjusted earnings of 7 cents, beating the consensus of 6 cents.Sales of $821.46 million, beating the consensus of $800.07 million. Revenue exceeded the high end of the company's implied fourth-quarter guidance, primarily a result of improved volume growth during the quarter.Performance MetricsSales increased 6.1% year-over-year. Same-facility revenue inc ...

U.S. stocks were higher, with the Nasdaq Composite gaining around 1% on Wednesday.Acadia Healthcare reported quarterly earnings of 7 cents per share which beat the analyst consensus estimate of 6 cents per share. The company reported quarterly sales of $821.459 million which beat the analyst consensus estimate of $800.065 million.Acadia Healthcare shares jumped 23.5% to $21.27 on Wednesday.Here are some other big stocks recording gains in today’s session.Photo via Shutterstock ...

Acadia Healthcare Company (NasdaqGS:ACHC) Q4 2025 Earnings call February 25, 2026 09:00 AM ET Company ParticipantsAnn Hynes - Managing DirectorDebbie Osteen - CEOJohn Ransom - Managing DirectorPatrick Feeley - SVP and Head of Investor RelationsSarah James - Managing DirectorThomas Walsh - Equity Research AssociateTodd Young - CFOConference Call ParticipantsA.J. Rice - Managing Director and Senior Equity Research AnalystAndrew Mok - Director and Senior Equity Research AnalystBen Hendrix - VP and Equity Resea ...